ENHANCING IMMUNOTHERAPY FOR TRIPLE-NEGATIVE AND HER2+ BREAST CANCER USING EPCAM APTAMER-SIRNA-MEDIATED GENE KNOCKDOWN.
$530,899FY2019Department of the ArmyDOD
Children'S Hospital Corporation, The
Investigators
View source on USAspending →ENHANCING IMMUNOTHERAPY FOR TRIPLE-NEGATIVE AND HER2+ BREAST CANCER USING EPCAM APTAMER-SIRNA-MEDIATED GENE KNOCKDOWN. · GrantIndex